Ab­b­Vie and Al­pha­bet's Cal­i­co added to Op­er­a­tion Warp Speed for rare dis­eases

Ab­b­Vie and Al­pha­bet’s Cal­i­co an­nounced Fri­day that their po­ten­tial treat­ment for the rare neu­ro­log­i­cal dis­ease known as van­ish­ing white mat­ter dis­ease will be part of …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER